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Abstract
The epithelial-to-mesenchymal transition (EMT) is an important event converting compact and
ordered epithelial cells into migratory mesenchymal cells. Given the molecular and cellular
similarities between pathological and developmental EMTs, studying this event during neural
crest development offers and excellent in vivo model for understanding the mechanisms
underlying this process. Here, we review new and old insight into neural crest EMT in search of
commonalities with cancer progression that might aid in the design of specific therapeutic
prevention.
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1. Introduction
The neural crest (NC) is a transient embryonic cell population characterized by its
multipotency and migratory ability. Induced at the boundary between neural and non-neural
ectoderm, the NC is specified via a well-orchestrated transcriptional program, now referred
to “gene regulatory network” [1–6]. As neurulation proceeds, NC precursors are restricted to
the dorsal aspect of the neural fold and neural tube, where they can be distinguished by the
expression of “neural crest specifier genes”. Subsequently, they undergo an epithelial-to-
mesenchymal transition (EMT) to become migratory NC cells that migrate extensively to
diverse locations. At their destinations, some undergo a reaggregation process via a
mesenchymal-to-epithelial transition (MET) and further differentiate into many types of
cells, ranging from neurons and glia of sensory, autonomic and enteric ganglia, to
adrenomedullary secretory cells, smooth muscle cells, melanocytes, and bone and cartilage
cells.
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NC cells have attracted the attention of embryologists for over a century as a model for
studying embryonic induction, specification, migratory potential and differentiation. In fact,
perturbation experiments yield very different anomalies depending upon the phase of NC
cell development that is disrupted (e.g., migration versus differentiation), with disruption in
NC EMT generally causing the most severe phenotypes. Interestingly, common signaling
pathways appear to occur during NC EMT as in other developmental EMTs such as those
occurring during gastrulation in the primitive streak, somite decondensation, cardiac valve
formation, etc. [7]. Notably, malignant cells also appear to use the same mechanisms to
delaminate from an epithelial tumor as those used by embryonic epithelial cells to
delaminate and migrate during development. This highlights the importance of
understanding the normal mechanisms of NC EMT as these might provide important clues
regarding the mistakes that lead to abnormal development or loss of the differentiated state.
In this review, we focus on new and old insights into NC formation as one of the best
studied developmental examples of EMT, highlighting their importance during
embryogenesis as well as a model for understanding cancer cells and tumor progression.
2. The EMT process in NC cells
A variety of in vivo and in vitro analyses in chick and Xenopus along with genetic studies in
the mouse and zebrafish have identified some of the cellular and molecular mechanisms
underlying EMT during NC cell delamination as well as some of the signaling cascades that
trigger these events (Fig. 1). After their specification, premigratory NC precursors from the
dorsal neural tube undergo an EMT process that can be parsed into several, sometimes
overlapping, steps that ultimately allow the precursors to leave the neural tube, becoming
bona fide NC cells that migrate through the extracellular matrix. The process of NC EMT
events requires: i) the coordinated activity of transcription factors and molecular signaling
pathways, ii) changes in cell junctions and polarity, iii) changes in adhesion properties, and
iv) changes in the extracellular matrix.
After EMT, the migratory ability of NC cells starts either prior to or soon after fusion of the
neural folds depending upon the vertebrate species [8]. Concomitantly, NC cells acquire
mesenchymal characteristics, as they express the intermediate filament vimentin and possess
a flattened morphology with filopodia and lamellipodia, facilitating their spreading [9–11].
Migratory NC cells follow stereotypical pathways depending upon their axial level of origin.
Cranial NC cells invade the surrounding cranial mesenchyme and ultimately condense to
contribute to various cranial ganglia and craniofacial cartilage and bones. Migratory NC
cells in the trunk that follow the ventral pathway differentiate into components of the
peripheral nervous system, while those migrating dorsolaterally become melanocytes [8].
2.1. Transcription factors
The signaling pathways utilized during EMT in the NC are similar to those that are active in
other developmental EMT process. Indeed, NC EMT is triggered by the integration of
extracellular signals, which include components of the extracellular matrix as well as a
number of secreted ligands including members of TGFβ, Wnt and FGF families. This initial
event is necessary to convert neuroepithelial precursors into migratory NC cells through
activation of a number of transcriptional regulators, including the zinc finger transcription
factors, Snail1 and Snail2 (formerly known as Slug), and the winged-helix transcription
factor FoxD3, which are critical factors that coordinate the cellular changes occurring during
EMT [5].
Snail—Snail promotes NC EMT by directly mediating transitions in cell-junction assembly,
motility and adhesion [5]. In chicks, NC cells express Snail2 whereas Snail1 is expressed in
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the mouse and both factors coexist in Xenopus [12–14]. Loss of function experiments in
chick and Xenopus result in a strong abrogation of cranial NC cell migration [12, 15, 16].
Conversely, gain-of-function experiments reveal that Snail1 in Xenopus and Snail2 in chick
are sufficient to induce expansion of the cranial NC territory and production of a greater
number of migrating NC cells. However, numerous observations suggest that Snail genes
may be neither sufficient nor necessary for NC cell specification and delamination, and may
play different roles at different axial level [12, 17, 18]. These results indicated that Snail-
expressing cells must either receive additional inputs or express other transcriptional
regulators at different axial levels to achieve specification and execute the EMT program.
Until recently, it was not possible to discriminate whether Snail genes functioned during
specification, delamination or both. However, several recent studies indicate that Snail can
regulate target genes, such as E-cadherin [19], as well as genes encoding structural proteins
that constitute the junction’s backbone such as claudin-3, claudin-4, claudin-7, and occludin
[20], by directly binding to E-box sequences within their promoters. In mouse and chick
embryos, a non-overlapping complementary mRNA expression pattern between Snail1/E-
Cadherin and Snail2/Cadherin-6B, respectively, has been observed at the boundary of the
ectoderm and the neural tube in the head region [19, 21]. Moreover, it has been
demonstrated in chick that Snail2 directly binds to Cad6B regulatory sequence and represses
it expression to allow NC cell delamination [21]. Conversely, Cad6B expression persists in
migrating NC in mouse and the trunk of chick embryos after cessation of NC cell
delamination [22–24]. Taken together, these results suggest that it is likely that Snail is not
the sole regulator of Cad6B expression in NC cells.
Snail2 and Sox5, a transcription factor belonging to the SoxD family, are able to upregulate
RhoB, a member of the Rho family of small GTPases [25]. RhoB exhibits a very dynamic
pattern in prospective NC cells prior to and during early migration [26] and is a well-known
regulator of events that change cell morphology necessary for NC delamination [27, 28].
These cellular changes involve actin cytoskeletal rearrangements as well as the formation of
focal adhesions and stress fibers [26]. Studies in chick and zebrafish have established that
Rho is necessary for cranial NC EMT [29, 30]. However, at trunk levels, it acts as a negative
modulator, downregulating N-cadherin [30].
Foxd3—In all species analyzed to date, Foxd3 is expressed in both premigratory and
migratory NC cells at all axial levels [31–36]. Gain and loss of function experiments in
different vertebrates have ascribed multiple functions to Foxd3 in NC cells, possibly through
recruitment of different partners at defined steps of development. Overexpression of Foxd3
promotes a massive EMT accompanied by a decrease in N-cadherin expression, alteration in
cell polarity, and upregulation of Cad7 [31, 37]. However, this effect is observed only two
days after overexpression, suggesting that the mechanism may be complex and involve
many secondary interactions, possibly including epigenetic modifications.
Although such loss and gain of function experiments are a good start toward understanding
the transcriptional network controlling NC cell EMT, the analysis is far from complete.
Several recent studies utilizing enhancer regulatory analysis, together with chromatic
immunoprecipitation (ChIP), DNA-pull down, and gel-shift assays have been able to
demonstrate direct regulatory interactions between transcription factors and key genes
related with EMT [38–40]. Further work along these lines is necessary to understand the
direct regulatory inputs controlling NC EMT.
2.2. Cadherins
Cadherins are a large family of calcium-dependent cell-adhesion molecules that play an
essential role in cell-cell interactions during NC EMT [22, 41]. In particular, the transition
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from the expression of type I cadherins (E-cadherin, N-cadherin, P-cadherin, R-cadherin),
which are usually associated with epithelial cells, to the expression of type II cadherins
(Cad5 and beyond), which characterize mesenchymal cells, are a hallmark of EMT. This
transition leads to much lower adhesiveness of NC cells and allows them to increase their
motility [42]. However, the repertoire of cadherins varies from one species to another,
suggesting that what is important in the progress of NC EMT is the switch between different
types of cadherin rather than the type itself. Moreover, this switch is quite complex as, in
different species and at different axial levels, premigratory NC cells express more than one
cadherin, and many others have been described in migrating cells [43]. Indeed, in zebrafish,
mouse and birds, premigratory NC cells co-express both N-cadherin and Cad6 or its variant,
Cad6B [22, 44, 45]. The significance of the co-expression of several cadherins and the
observed axial level differences in their regulation in prospective NC cells are largely not
understood and require further elucidation. During NC EMT, N-cadherin and Cad6b are
downregulated in the prospective NC within the closing dorsal neural tube through FoxD3
and Snail2 activity, respectively [21, 37]. As NC cells exit the neural tube, the expression of
Cad7 (in birds) and Cad11 (in mouse and Xenopus) are up-regulated, possibly by the
combined action of the NC specifiers FoxD3 and Sox10 [22, 23, 37, 46, 47].
2.3. Junctions
The apical zones of premigratory NC cells are joined by intercellular junctions until fusion
of the neural folds begins. Starting at this time, the junctions progressively disappear and the
cells lose their apico-basal polarity [9, 48]. Occludin and claudin, which are the major
components of tight junctions, are downregulated from the neural tube and a de-
epithelization process takes place before the onset of NC cells migration [49, 50]. The
dissolution of tight junctions seems to be directly regulated by Snail [20]. Similar to the
transition that occurs in cadherins, there is a transition from tight junctions to gap junctions
in the prospective NC cells prior to EMT [For review see 5]. For example, the gap junction
protein connexin-43α1 (Cx43α1) is expressed in migrating NC cells at all axial levels [51]
and its knockout produces defects in NC derivatives, possibly via dynamic regulation of the
locomotory apparatus [52].
2.4. Extracelular matrix
The extracellular matrix (ECM) is not a passive structure that allows the movement of NC
cells. Rather, the ECM is comprised of a dynamic milieu of collagens, fibronectin, laminins,
vitronectin and proteoglycans, that together with integrin molecules on NC cells themselves
play an active role during the EMT process [53]. In addition to switching cadherin
expression, digestion of the extracellular matrix in the basement membrane that overlies the
dorsal neural tube is a necessary step to achieve full NC EMT [54]. This job is carried out by
membrane-bound and/or secreted forms of proteins called matrix metalloproteases (MMPs).
MMP2 is one of the most common metalloproteases that plays an important role in NC
migration. Indeed, specific morpholino knockdown of MMP2 expression in the dorsal neural
tube disturbs NC cell EMT [55]. Consistent with this, the Ets1 transcription factor is known
to induce the expression of MMPs and is upregulated in cranial NC cells precisely at the
time of NC cell delamination in the chick and frog [56, 57]. Under normal condition, MMP2
is rapidly downregulated in migrating NC by tissue inhibitors of MMPs (TIMPs), such as
TIMP-2, and has an important role on cardiac migratory NC cells [55, 58, 59]. In addition to
the NC, MMPs are also expressed in various human cancer cells [60–63].
NC cells also express several other MMPs, including members of the novel transmembrane
metalloprotease family ADAM [64, 65], such as ADAM-10 in the chick [66] and ADAM13
in the frog [67–69]. These are membrane-bound enzymes that cleave the extracellular
portion of transmembrane proteins, thereby affecting cell-cell adhesion. ADAM10,
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expressed in the dorsal neural tube [66], is able to cleave the extracellular domain of N-
cadherin resulting in the deterioration of the intercellular junctions [70]. Moreover, the
remaining part of N-cadherin molecule is further cleaved off from the membrane and its
CTF2 intracellular peptide acts as a transcriptional regulator [71]. This demonstrates a dual
function for the proteolytic degradation of N-cadherin, which acts as a critical trigger for
EMT. On the other hand, ADAM13 has been shown to cleave fibronectin and proposed to
facilitate cell migration by locally reorganizing the fibronectin network [67].
NC cells express different integrins receptors that alter their contacts with the ECM
following EMT. Loss-of-function studies have shown that integrins play an essential role in
NC migration [72–76].
2.5. Epigenetic factors
Many studies in a variety of different vertebrate models have revealed critical roles for
transcription factors in establishing the “gene regulatory network” that controls NC
development [2]. Although each NC cell generally shares the same genetic information with
every other, there are intrinsic properties giving them particular characteristics in terms of
migration and differentiation capacities. In this context, a growing body of evidence has
emerged demonstrating that epigenetic mechanisms also play a critical role in NC
development [77–80]. Moreover, in this regulation not only the “writing” of the “epigenetic
code”, but also the “reader”, play an important role in the fine tuning of gene expression and
specific biological outcomes.
We recently reported that a dynamic histone modification is necessary for the proper
temporal control of NC gene expression in vivo [80]. Accordingly, we described that the
demethylation of H3K9me3 by JmjD2A is required for activation of several key NC
specifier genes in the chick embryo. Expression of JmjD2A was found in the forming dorsal
neural tube, and loss of JmjD2A function causes dramatic downregulation of several NC
specifier genes, such as Sox9, Sox10, FoxD3, and Snail2. Importantly, in vivo chromatin
immunoprecipitation reveals direct stage-specific interactions of JmjD2A with regulatory
regions of Sox10 and associated temporal modifications in the methylation states of lysine
residues directly affected by JmjD2A activity. Our findings show that chromatin
modifications directly control the setting up of a developmental program for NC
specification in vertebrate embryos via modulating histone methylation.
There are now diverse examples of the effects of different epigenetic modifications on NC
cells or their derivatives. For example, histone acetylation, regulated by the histone
deacetylase HDAC8, seems to have a unique role in cranial NCCs differentiation into facial
skeleton [77]. It was further demonstrated that HDAC8 is required for the suppression of
Otx2, Lhx1, and other homeobox transcription factors in cranial NC cells. Intriguingly, this
affected skull elements, but no other NC derived tissues [77]. Differentiation of human wild-
type ES cells into migratory neural crest-like cells (hNCLCs) was significantly inhibited by
the depletion of the ATP-dependent chromatin remodeling chromodomain Helicase DNA-
binding protein 7 (CHD7) [81]. Similarly, depletion of the CHD7 in Xenopus embryos
resulted in drastic downregulation of three NC specifiers (Slug/Snail, Twist, and Sox9), due
to a regulation of distal enhancer elements, which in turn regulate cranial NC cell migration
in the developing pharyngeal arches [82].
Finally, it has been recently demonstrated that Aebp2, a potential targeting protein for the
mammalian Polycomb Repression Complex 2 (PRC2), is upstream of several NC genes
involved in migration and development processes [78]. In addition, many heterozygotes
mouse display a set of phenotypes, such as enlarged colon and hypopigmentation, similar to
those observed in human patients with Hirschsprung’s disease and Waardenburg syndrome.
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These phenotypes are usually caused by the absence of the NC-derived ganglia in hindguts
and melanocytes [78].
Taken together, it is becoming clear that epigenetic mechanisms play a major role in NC
development. However, there role in the EMT process is still poorly understood. It will be of
great interest to map out the epigenetic regulation network during NCC development using
highthroughput analysis such as ChIP-seq.
3. Cranial versus trunk NC cells EMT
Although it is tempting to try to present a single, unifying model to describe the molecular
cascade leading to NC cell EMT, it has become increasingly evident that the process is
heterogeneous. This is largely due to the heterogeneity of the NC population at different axis
levels. Thus, NC cell EMT involves distinct cellular and molecular mechanisms that vary
along the neural axis. Cranial NC cell delamination involves the cooperation of multiple
regulators recruited simultaneously in a short period of time concomitant with the
neurulation process. On the other hand, trunk NC cell delamination is more progressive,
involving a restricted number of transcription factor and is comparatively delayed with
respect to the neurulation. Moreover, it has been extensively demonstrated that the role the
EMT players vary at different axial levels. For example, the expression of Snail genes varies
in an axis dependent manner [12–14]. Particularly in chick, Snail2 is generally induced very
precociously in cranial NC, long before neural tube closure, and persists during
delamination as well as in early migrating NC cells to gradually disappear as they reach the
ventral portion of the embryo. However, in the chick trunk, Snail2 expression appears soon
after neural tube closure, and becomes repressed once cells start the migration [83]. In
contrast to Snail2, Sox9 is required for the trunk NC development but not for cranial [37].
There are also cranial and trunk differences related to cadherin regulation. For example, in
chick, Cad6B is expressed only in premigratory cranial NC and appears to prevent their
delamination from the neural tube [84]. Later on, Snail2 directly downregulates Cad6B
expression to induce the NC EMT [21]. On the other hand, Cad6B expression persists in
early migrating trunk NC just after they have undergone an EMT and emigrated from the
neural tube [24]. Similarly, in mouse, Cad6 expression persists in a subpopulation of early
migrating NC [44]. Likewise, in the head both N-Cad transcripts and proteins are absent
from the entire prospective NC cell population at the time of fold fusion, delineating cells
undergoing EMT [8, 41, 85]. However, in the trunk, N-Cad transcripts are maintained in NC
cell progenitors until their completely segregate from the neural tube [86].
As mentioned above, RhoB has different functions in cranial versus trunk NC cells. In the
head, RhoB is responsible for mediating changes in the cell morphology necessary for NC
delamination, but in the trunk acts as a negative modulator downregulating N-Cad [30].
There are also head and trunk differences in term of cell-cycle control. Studies show that
premigratory NC cells in the trunk are arrested in the G1 phase and synchronously enter the
S phase upon delamination. Snail, expressed in premigratory cells, represses the expression
of cyclin D1 and D2 preventing the progression of G1-S. Upon delamination, Snail
expression decreases, which allows the cyclin levels to rise and the cell-cycle to progress
[87]. However, in the head the dynamics of the delamination process vary considerably. In
contrast to the trunk, cranial NC cells delaminate en masse from the dorsal neural tube under
the influence of the Ets1 transcription factor, which activity abolishes the necessity of the
G1-S transition [57].
Pablo H. and Marianne E. Page 6
Semin Cancer Biol. Author manuscript; available in PMC 2013 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
4. Conclusion
Here, we review the molecular mechanisms involved in NC EMT. As a general trend, the
NC EMT process involves a myriad of molecular cascades resulting in a variety of cellular
events that ultimately control cell-cell and cell-matrix adhesion, cell proliferation, and cell
survival. To date, there is no single, simple mechanism that can describe the process of NC
EMT and delamination. Rather, there appear to be a variety of mechanisms that lead to the
same goal, depending upon the axial level of NC origin. It seems very likely that malignant
cells use similar mechanisms to delaminate from an epithelial tumor as those used by
embryonic NC cell. In this context, in-depth understanding of the EMT process occurring
during normal embryonic development may contribute to the specific design of therapeutic
treatment to stop the metastatic cascade and tumor progression.
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Figure 1.
(A) Schematic representation of the genes expressed on neural crest cells prior (green) and
after (red) undergoes epithelial-to-mesenchymal transition. (B) Neural crest epithelial-to-
mesenchymal transition regulation. NC specifiers, FoxD3 and Snail down-regulate
expression of molecules that are associated with epithelial static cell populations, such as N-
Cad and E-Cad (or Cad6B in chick and mouse), respectively, to give place to the up-
regulation of mesenchymal migratory proteins, such as Cad7. Similarly, Snail down-
regulates tight junction claudins/occludins to permit the upregulation of gap junction protein
connexin-43α1 (Cx43α1), which may also depend on Snail expression. Gene regulation in
which the repressors Snail or FoxD3 up-regulate the expression of matrix metalloproteases
(MMPs), integrins, Cad7 or RhoB may denote indirect regulatory interactions, possibly
mediated by other repressors (represented by dotted lines).
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